These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1444)

  • 21. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host vs graft and graft vs host reactions after allogeneic heterotopic small bowel transplantation in the rat.
    Gasser M; Prange K; Schroeder P; Stoffregen C; Eckstein V; Deltz E
    Transplant Proc; 1992 Jun; 24(3):1128-9. PubMed ID: 1604550
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of humoral factors in the mechanisms of graft-versus-host induced host cell proliferation and lymph node hyperplasia in the rat.
    Rolstad B
    Lymphology; 1980 Dec; 13(4):197-201. PubMed ID: 7206787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):167-73. PubMed ID: 9515226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of regional and distant lymph nodes in rejection of feline sarcoma virus-induced tumors in sheep.
    Thellen GH; Pedersen NC; Higgins J
    J Natl Cancer Inst; 1979 Aug; 63(2):389-400. PubMed ID: 222930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of age on the response of rat lymphocytes in mixed leukocyte culture, to PHA, and in the graft-vs-host reaction.
    Nielsen HE
    J Immunol; 1974 Mar; 112(3):1194-200. PubMed ID: 4149562
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent movement of surface immunoglobulin from Fc receptors on lymphocyte membranes.
    Ramasamy R; Lawson Y
    Immunology; 1975 Feb; 28(2):301-4. PubMed ID: 1123249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Level and temporal pattern of naturally cytolytic cells during acute Graft-versus-Host Disease (GVHD) in the rat.
    Clancy J; Mauser L; Chapman AL
    Cell Immunol; 1983 Jul; 79(1):1-10. PubMed ID: 6602659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment.
    Ryffel B; Feurer C; Heuberger B; Borel JF
    Immunobiology; 1982 Dec; 163(5):470-83. PubMed ID: 6984418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.
    Soulillou JP; Carpenter CB; d'Apice AJ; Strom TB
    J Exp Med; 1976 Feb; 143(2):405-21. PubMed ID: 129499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of mast cell, fibroblast, and epidermal cell proliferation during acute graft-versus-host disease in the neonatal rat.
    Stuart SP; Klein RM; Clancy J
    J Invest Dermatol; 1987 Apr; 88(4):369-74. PubMed ID: 3559263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of 70-kDa heat-shock protein during acute graft-versus-host disease.
    Goral J; Mathews HL; Clancy J
    Clin Immunol Immunopathol; 1998 Mar; 86(3):252-8. PubMed ID: 9557158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of a heterologous tumor cell line in neonatal rats with graft-versus-host disease.
    Clancy J; Chapman AL; Holt R
    J Natl Cancer Inst; 1977 May; 58(5):1279-85. PubMed ID: 16141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.